Powder: -20°C for 3 years | In solvent: -80°C for 1 year
2-hydroxy Flutamide is competitive inhibition of androgen receptor (AR) for the treatment of prostate cancer
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 11,000 | |||
10 mg | 在庫あり | ¥ 18,500 | |||
25 mg | 在庫あり | ¥ 35,500 | |||
50 mg | 在庫あり | ¥ 55,000 | |||
100 mg | 在庫あり | ¥ 85,500 | |||
200 mg | 在庫あり | ¥ 126,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,500 |
説明 | 2-hydroxy Flutamide is competitive inhibition of androgen receptor (AR) for the treatment of prostate cancer |
In vitro | The pharmacologically active metabolite 2-hydroxy-flutamide, this principle metabolite increased CYP3A metabolism of midazolam in human microsomes (30%) and hepatocytes (110%)[1]. |
分子量 | 292.21 |
分子式 | C11H11F3N2O4 |
CAS No. | 52806-53-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25mg/ml(85.5 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
2-hydroxy Flutamide 52806-53-8 Endocrinology/Hormones Androgen Receptor Inhibitor inhibit prostate cancer HFT Flutamide 2 hydroxy Flutamide 2hydroxy Flutamide Hydroxyflutamide inhibitor